亚洲社会药学

• 论文 •    下一篇

Research on Preferential Tax Policies Related to Pharmaceutical R&D in China

Fan Yulu, Chen Yuwen*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • 出版日期:2018-03-20 发布日期:2018-06-05

Research on Preferential Tax Policies Related to Pharmaceutical R&D in China

Fan Yulu, Chen Yuwen*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Online:2018-03-20 Published:2018-06-05
  • Contact: Chen Yuwen, professor. Major research area: pharmacy administration, new drug research and development, etc. Tel.: 024- 23986552, E-mail: cywwyc@163.com.

摘要: Objective To find out the problems in tax policies related to pharmaceutical R&D in China so as to put forward some suggestions for making preferential tax policies. Methods Preferential tax policies related to pharmaceutical R&D from the Ninth-Five-Year to the Twelfth-Five-Year period of China were selected and analyzed through text analysis methods. Results and Conclusion Current preferential tax policies are not targeted and systematic. The preferential tax policies should be designed to motivate small and medium-sized enterprises and the tax incentives must have a sustainable effect. Government should reinforce its proactive tax incentives and shift from the direct preferential tax policies to the indirect ones gradually.

关键词: R&D, pharmaceutical industry, preferential tax policy, text analysis

Abstract: Objective To find out the problems in tax policies related to pharmaceutical R&D in China so as to put forward some suggestions for making preferential tax policies. Methods Preferential tax policies related to pharmaceutical R&D from the Ninth-Five-Year to the Twelfth-Five-Year period of China were selected and analyzed through text analysis methods. Results and Conclusion Current preferential tax policies are not targeted and systematic. The preferential tax policies should be designed to motivate small and medium-sized enterprises and the tax incentives must have a sustainable effect. Government should reinforce its proactive tax incentives and shift from the direct preferential tax policies to the indirect ones gradually.

Key words: R&D, pharmaceutical industry, preferential tax policy, text analysis